Stocks to watch: CICT, Keppel, Clar, Thomson Medical, Zheneng Jinjiang Environment

Shikhar Gupta
Published Mon, Aug 11, 2025 · 08:32 AM
    • CapitaLand Integrated Commercial Trust has received in-principal approval for the listing and quotation of 284.4 million new units.
    • CapitaLand Integrated Commercial Trust has received in-principal approval for the listing and quotation of 284.4 million new units. PHOTO: RENDY ARYANTO, VVS.SG

    [SINGAPORE] The following companies saw new developments that may affect trading of their securities on Monday (Aug 11):

    CapitaLand Integrated Commercial Trust (CICT) : The manager of the trust announced on Monday the in-principle approval of the listing and quotation of 284.4 million new units at an issue price of S$2.11 per new unit for a placement of around S$600 million. These will be listed on the Singapore Exchange mainboard. Units of the trust closed flat at S$2.26 on Friday.

    Keppel : The group announced on Monday its proposed divestment of M1’s telecommunications business to Simba Telecom for an enterprise value of around S$1.4 billion. The consideration will be fully paid in cash and Keppel will receive close to S$1 billion in cash proceeds for its 83.9 per cent effective stake in M1. Shares of Keppel closed on Friday 0.8 per cent or S$0.07 down at S$8.58, before the news. It called for a trading halt on Monday morning.

    CapitaLand Ascendas Reit (Clar) : The manager on Monday announced the proposed development of Clar’s first logistics developments in the UK, for an estimated total investment cost of S$350.1 million. The trust is proposing to acquire two plots of freehold land, on which four new logistics properties will be developed. The new properties are set to boost the asset value of Clar’s UK logistics portfolio by 43.5 per cent to around S$1.2 billion. Units of Clar finished on Friday 0.4 per cent or S$0.01 lower at S$2.72.

    Thomson Medical Group : The medical group announced on Friday night that it is expected to record a post-tax loss for the six months and financial year ended Jun 30. It cited higher interest expenses from its Far East Medical Vietnam acquisition, cessation of projects in Singapore and weaker performance in Malaysia – partly from the termination and discounts of certain insurance contracts – as primary reasons for the dip. The counter closed 3.6 per cent or S$0.002 down at S$0.053 on Friday.

    Zheneng Jinjiang Environment : The China-based waste treatment group on Saturday posted a profit of 332 million yuan (S$59.4 million) for its first half ended Jun 30, up from 206.9 million yuan in the previous corresponding period. Its revenue stood at 1.82 billion yuan, a marginal increase of 0.6 per cent from 1.81 billion yuan in H1 2024. The counter finished on Friday flat at S$0.45.

    Copyright SPH Media. All rights reserved.